chrX-80025598-T-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 4P and 12B. PS3BP4_StrongBS1BS2

The NM_001109878.2(TBX22):​c.459-5T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000297 in 1,204,932 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 115 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000589509: A functional study showed the c.459-5T>A variant almost abolished the wild type splicing product and led to a significant increase in the most upstream cryptic splice site product of exon 4 (Pauws et al., 2013).".

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., 7 hem., cov: 22)
Exomes 𝑓: 0.00031 ( 0 hom. 108 hem. )

Consequence

TBX22
NM_001109878.2 splice_region, intron

Scores

2
Splicing: ADA: 0.4644
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:1B:1

Conservation

PhyloP100: 1.80

Publications

2 publications found
Variant links:
Genes affected
TBX22 (HGNC:11600): (T-box transcription factor 22) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. Mutations in this gene have been associated with the inherited X-linked disorder, Cleft palate with ankyloglossia, and it is believed to play a major role in human palatogenesis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TBX22 Gene-Disease associations (from GenCC):
  • cleft palate with or without ankyloglossia, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • Abruzzo-Erickson syndrome
    Inheritance: XL Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000589509: A functional study showed the c.459-5T>A variant almost abolished the wild type splicing product and led to a significant increase in the most upstream cryptic splice site product of exon 4 (Pauws et al., 2013).
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000188 (21/111699) while in subpopulation NFE AF = 0.00032 (17/53154). AF 95% confidence interval is 0.000203. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 7 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001109878.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBX22
NM_001109878.2
MANE Select
c.459-5T>A
splice_region intron
N/ANP_001103348.1Q9Y458-1
TBX22
NM_016954.2
c.459-5T>A
splice_region intron
N/ANP_058650.1Q9Y458-1
TBX22
NM_001109879.2
c.99-5T>A
splice_region intron
N/ANP_001103349.1Q9Y458-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBX22
ENST00000373296.8
TSL:5 MANE Select
c.459-5T>A
splice_region intron
N/AENSP00000362393.3Q9Y458-1
TBX22
ENST00000373294.8
TSL:1
c.459-5T>A
splice_region intron
N/AENSP00000362390.5Q9Y458-1
TBX22
ENST00000626877.1
TSL:1
n.338-5T>A
splice_region intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.000188
AC:
21
AN:
111699
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000326
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000947
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000320
Gnomad OTH
AF:
0.00136
GnomAD2 exomes
AF:
0.000203
AC:
37
AN:
182657
AF XY:
0.000282
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000369
Gnomad OTH exome
AF:
0.000885
GnomAD4 exome
AF:
0.000308
AC:
337
AN:
1093233
Hom.:
0
Cov.:
29
AF XY:
0.000301
AC XY:
108
AN XY:
358781
show subpopulations
African (AFR)
AF:
0.000608
AC:
16
AN:
26310
American (AMR)
AF:
0.00
AC:
0
AN:
35201
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19355
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30185
South Asian (SAS)
AF:
0.000111
AC:
6
AN:
54052
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40497
Middle Eastern (MID)
AF:
0.00534
AC:
22
AN:
4118
European-Non Finnish (NFE)
AF:
0.000315
AC:
264
AN:
837607
Other (OTH)
AF:
0.000632
AC:
29
AN:
45908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000188
AC:
21
AN:
111699
Hom.:
0
Cov.:
22
AF XY:
0.000207
AC XY:
7
AN XY:
33857
show subpopulations
African (AFR)
AF:
0.0000326
AC:
1
AN:
30684
American (AMR)
AF:
0.0000947
AC:
1
AN:
10565
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2655
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3545
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2635
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000320
AC:
17
AN:
53154
Other (OTH)
AF:
0.00136
AC:
2
AN:
1476
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000651
Hom.:
4
Bravo
AF:
0.000155
EpiCase
AF:
0.000818
EpiControl
AF:
0.000711

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
1
not provided (2)
1
-
-
Abruzzo-Erickson syndrome (1)
1
-
-
Cleft palate with or without ankyloglossia, X-linked (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
16
DANN
Benign
0.68
PhyloP100
1.8
Mutation Taster
=97/3
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.46
dbscSNV1_RF
Benign
0.42
SpliceAI score (max)
0.37
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.37
Position offset: 5
DS_DG_spliceai
0.30
Position offset: 4

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200060292; hg19: chrX-79281097; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.